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Introduction
Percutaneous coronary intervention (PCI) in bifurcation lesions
remains complex in many respects. Part of the complexity relates 
to the variety of situations, definitions, treatment and outcomes
which are related to this anatomical configuration. In order to devel-
op a consensual view on the many aspects of coronary bifurcation
lesions, the European Bifurcation Club (EBC) was created in 2005.
The first EBC meeting took place in Bordeaux and some consensus
emerged1. 
Briefly, the participants agreed that: a) the Medina classification
should be adopted2, b) with bare metal stents, a stepwise provisional
T-stent strategy is the gold standard, c) with bare metal stents, 
deliberate double-stenting may be an inferior technique, d) with drug-
eluting stents, the optimal strategy is under development and ongo-
ing trials (Nordic and BBC1) will help to define it, e) after complex
stenting, kissing balloon inflations should be routinely performed.
Several problems were still unsolved, however. Some of the debat-
ed issues as well as the previously adopted ideas were discussed,
with respect to the recent clinical and technical developments, dur-
ing the second EBC meeting which was held in Rome on September
29th to 30th, 2006. This manuscript highlights the discussions, 
disputes and consensus which emerged from this meeting.
Definitions
A simple description of the treated lesion, stenosis quantification
and PCI technique is not straightforward. Following the first and
second EBC meetings, a general consensus emerged and led to the
publication of a paper which describes the classification of coronary
artery bifurcation lesions and treatments3. Figure 1 describe the
Medina classification (lesion description) and Figures 2 and 3 the
MADS classification (treatment description) which are unanimously
accepted by the EBC. These classifications may need some refine-
ments, however, and take into consideration the angle between the
two branches, the lesion length, the observed/expected diameter,
the TIMI flow, presence of calcification, plaque situation or eccen-
tricity, ulceration, but all these aspects are hampered by the limita-
tions of an accurate quantitative coronary angiography evaluation
which is still operator dependent and thus subjective. Novel bifur-
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cation software may solve some, but not all problems. A single
analysis of the 3 vessels is made possible while considering the 
constant reference vessel diameter (RVD) relation between proximal
vessel diameter (PVD), distal vessel diameter (DVD) and side
branch diameter (SBD) such as PVD=0.678 x (DVD+SBD)4.
However, QCA is still limited at the level of carina which reference
diameter is interpolated for the segment analysed and cannot be
assessed in a single view most of the time.
Anatomopathology and physiopathology
Pathologic examination of coronary arteries reveals that the athero-
sclerotic plaques are located mainly along the inner side of the
curved coronary arteries, close to the areas of minimum shear
stress. Regions exposed to the non-uniform shear stresses develop
early atherosclerotic lesions while areas exposed to uniform shear
stresses are protected5-12. Consequently, atherosclerotic plaque
usually develops opposite of the site branch13-16. Seen in this light,
alterations in flow pattern may be critically important, not only for
the comprehension of lesion geometry, but also when considering
that the same mechanism favours intimal hyperplasia, and thus 
in-stent restenosis following stent implantation. Thus, in the setting
of flow disturbances such as observed in bifurcation lesions, high
restenosis rates are expected with bare metal stents, which could
be offset by drug eluting stent placement.
Although there is a correlation between the stenosis severity of the
side branch (SB) and its physiological significance following stent
implantation in the main vessel (MV), Koo17 has shown that about
70% of ostial SB lesions following MV stenting are not functionally
significant. In this very important study, no lesion with < 75% SB
stenosis by QCA had a fractional flow reserve (FFR) < 0.75. Wide
variations in FFRs were shown even in SB lesions with > 75%
stenosis by QCA suggesting that in some cases “significant” side
branch lesions after main branch stenting should not treated. On
the opposite side, in this study, final kissing balloon inflation of
physiologically SB stenosis (FFR < 0.75), was associated with
excellent clinical outcome. Therefore, FFR assessment of SB ostial
lesions after MV stenting or the use of a better angiographic cut-off
value may be advocated before performing kissing balloon, and/or
stenting of the SB.
Technique
One of the problem encountered in bifurcation stenting is plaque
shift and carena shifting leading to SB stenosis and sometimes
occlusion. There is therefore some arguments to predilate both
main and side branch before stenting, at least for severely stenosed
(> 95%) SB in order to minimise the potential for ischaemia and 
to facilitated subsequent SB dilatation and stenting. Although some
believe that SB predilatation is not critical providing that a wire 
is already placed, there is a general consensus to predilate any
ostial calcified or long SB lesion as well as when plaque burden in
both branches is high with a big myocardial mass at risk. However,
when the strategy is provisional SB stenting, SB predilatation can
cause a SB dissection which may be associated with SB access 
difficulties through the stent strut. Therefore, in case of significant
SB dissection after SB predilatation it could be preferable to switch
to a different strategy and stent the SB first. 
The systematic use of a jailed wire in the SB is also debated.
Whenever possible the “Keep It Simple Swift and Safe” (KISSS) prin-
ciple is recommended. However, the jailed wire technique modifies
favourably the angle between both branches, is a good marker of SB
and thus helps you to perform a provisional SB stenting approach. 
It should always be considered in the more complex anatomy.
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Final kissing balloon has been recommended to optimise stent
apposition, correct stent deformation or distortion and improve side
branch access. However, there is no consensus to recommend final
kissing balloon in all bifurcation PCI. In addition, in the current era
of drug eluting stents, final kissing balloon does not seem to be an
essential factor for securing late clinical success and there are no
randomised studies which have addressed specifically this techni-
cal issue. Therefore, the common sense is to recommend final kiss-
ing balloon for the complex lesions (1,1,1 or 1,0,1 or 0,1,1) or pro-
cedures (2 stents or more).
In most bifurcation lesions, one stent is the treatment of choice. 
In a “true” bifurcation lesion (Medina classification 1,1,1; 1,0,1 
or 0,1,1), the strategy of elective implantation of 2 stents may be
considered, especially when the side branch lesion is longer that 
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2 or 3 mm18, but there are no consensus on which of the different
two stent methods gives the best result on a long term basis. Even
more, should we be performing complex strategy in all complex
bifurcation lesions? The recent Nordic Bifurcation Study19 com-
pared a simple stent strategy (stenting of the main vessel and
optional treatment of SB) with a complex strategy (stenting both
main vessel and SB). Results of this pivotal study support the sim-
ple strategy in most situations, but the overall conclusions may not
be valid for specific subsets of lesions. More data are still to be col-
lected to define which is the strategy best adapted for each of the
different anatomic situations. The results of BBC 1 study which 
will be available this year will be very important to try to answer 
this very crucial question.
Stent thrombosis and restenosis rate
Stent thrombosis has emerged recently as a major drawback of DES
implantation. Iakovou et al were the first to address the increased
risk of late stent thrombosis following bifurcation stenting with
DES20. Although it appears that bifurcation compared to non-bifur-
cation treatment with DES is associated with a higher stent throm-
bosis rate21,22, except in the recently published ARTS II sub-study23,
there is no proven difference between rates of thrombosis after DES
vs BMS treatment of bifurcation lesions. Nevertheless, post proce-
dural stent thrombosis has been reported in 0 to 7.2% of cases after
bifurcation stenting with DES (Figure 4). If there is a trend toward 
a higher rate of stent thrombosis when using 2 stents, there is 
no clear demonstration that one stent technique is better than 
two stent methods, and explanations for increased thrombosis rates
in bifurcation lesions are speculative. It is worth noting that treat-
ment of bifurcation with DES is not an approved FDA indication and
should therefore be considered with caution until more data are
available on their long term safety. It was a consensus of this group
that treatment of bifurcation with DES should be closely monitored
in clinical trials or registries.
Low shear stress is associated with blood stagnation and therefore
may participate in in-stent thrombosis as well as to neointimal 
proliferation. At least on theoretical grounds, great care should
therefore be taken when designing dedicated stents for bifurcation
or when performing complex two-stents techniques. Specifically,
preliminary data suggests that high bifurcation angle (> 50°) has 
a negative impact on outcomes following crush, SKS or culotte tech-
niques35. This may have very important consequence in left main
stenting but more work is needed to decide on the clinical impor-
tance of coronary rheology.
Insights from ARTS II or REALITY studies and Research, T-search
or Asian bifurcation registries support the use of DES which is asso-
ciated with a low restenosis rate of one digit in the main branch and
>10% only in the SB. Although outcomes appear similar with the
different type of DES (sirolimus vs paclitaxel coated stent) and either
using one or two-stents treatment strategies, more data are needed
to confirm how might the DES matter.
Dedicated stents
The role of dedicated devices for the treatment of bifurcation lesion
is still under investigation. There is a great hope that it will be the
next step that will make bifurcation treatment easy for everybody
especially for distal left main treatment. However, we are still 
waiting for the magic device. Preliminary results of the DES 
carena device (Devax™) assessed in the Axxess Plus study36 look
promising. This dedicated stent appears safe and effective.
Whether it represents an advance with respect to the current tech-
niques needs to be evaluated. 
Other DES dedicated devices are under development: The SideKick™
stent delivery system and the Stentys™ bifurcation stent are prom-
ising techniques allowing excellent SB access, the former being
soon assessed in randomised study. The Capella™ sideguard
ostium protection device and the Tryton™ side branch stent aim 
to optimise the SB coverage in combination with a stent placed 
in the main vessel. First-in-man trials are ongoing with the
Capella™ and Tryton™ devices.
Left main
Whether distal left main stenosis has to be treated like any bifurca-
tion lesion is debated37. Most participants would consider the same
stenting PCI approach as for any bifurcation lesion, bearing in mind
that there are three segments to treat, the reference diameter is
large, the “SB” is significant with T shape angle and the coronary
ostium should not be missed. In addition, stent thrombosis is not
allowed. Accordingly, most procedures can be performed using the
provisional SB T-stenting approach, with the need for additional SB
stenting in 20 to 40% and final kissing balloon in all cases.
Systematic use of two stents techniques may not be advocated
because they are probably associated with higher risk of reinterven-
tion and stent thrombosis. Results of ongoing registries and ran-
domised trials, such as SYNTAX are awaited to better define the
strategy and indications of PCI on unprotected left main bifurcation
who should be performed electively by experienced interventional
operators in high volume institutions PCI and in patients not eligible
for surgery.
Figure 4. Occurrence of early and late (1 year) stent thrombosis in
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Conclusions
Bifurcation lesions remain a challenging problem for PCI. Part of the
complexity relates to the number of anatomic situations, the variety
of interventional approaches, the worries over late outcomes and
the limitations in anatomic as well as physiologic assessments.
There are still many issues to solve and to debate. However, during
this two day meeting some progress was made in the search for a
standard approach.
WHAT WE ALL AGREE:
– The MEDINA classification of coronary bifurcation lesion and the
MADS classification for treatment techniques should be adopted.
– QCA software needs to be standardised, with appropriate algo-
rithms allowing multiple segment of interest analysis.
– With BMS, as well as with DES, a stepwise provisional T-stenting
strategy is the best.
– Deliberate double stenting is an inferior technique.
– SB predilatation is recommended if calcified lesion or long lesion.
– Jailed wire is strongly recommended in complex lesions.
– After complex stenting (for complex lesions), kissing balloon infla-
tions should be routinely performed.
WHAT IS STILL DEBATED:
– A validated software for QCA of bifurcations is still being waited for.
– An accurate evaluation of the functional significance of ostial SB
stenosis is necessary.
– Should we do systematic kissing balloon inflation?
– Are DES really more thrombogenic? If yes, how to reduce the risk?
– What is the future of dedicated bifurcation devices?
– The optimal strategy for the treatment of distal left main bifurcation 
is under development, clinical trials and registries will help to define it.
– Solutions of the many problems dealing with bifurcation lesions
depend on the collection of a large clinical experience. Therefore,
the decision was taken at the end of this conference to create 
a specific e-CRF that would allow the collection of thousands 
of coronary bifurcation procedures and outcomes. With the use 
of this tool, we hope to be able to solve some of the remaining
issues and to further expand our knowledge on one of the most
debated issues of interventional cardiology.
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